AA
TMO icon

Argent Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Argent Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Sell
507
-49
-9% -$23.5K 0.06% 165
2026
Q1 		$273K Sell
556
-9
-2% -$4.88K 0.07% 147
2025
Q4 		$327K Hold
565
– – 0.09% 139
2025
Q3 		$274K Buy
+565
New +$263K 0.08% 142
2020
Q1 		– Sell
-5
Closed -$1K – 464
2019
Q4 		$1K Buy
+5
New +$1.52K ﹤0.01% 464

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Argent Advisors's TMO Position: Q2 2026 in Review

Argent Advisors reduced its Thermo Fisher Scientific (TMO) stake by 8.8% in Q2 2026, selling an estimated $23.5K and leaving 507 shares worth $254K. The position accounts for 0.06% of the portfolio, ranked #165.

Argent Advisors first reported a position in TMO in Q4 2019 and has held it in 5 quarters since. The position peaked at $327K in Q4 2025. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Argent Advisors held 507 shares of Thermo Fisher Scientific worth $254K as of Q2 2026.
  • Argent Advisors sold 49 Thermo Fisher Scientific shares in Q2 2026, an estimated $23.5K.
  • Thermo Fisher Scientific made up 0.06% of Argent Advisors's portfolio in Q2 2026, its #165 holding.
  • Argent Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 5 quarters since.
  • Argent Advisors's Thermo Fisher Scientific position peaked at $327K in Q4 2025.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Argent Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.